REPLACING MANUAL PROCESSING OF FUND PERFORMANCE REPORTS, CAPITAL ACCOUNT STATEMENTS, AND CASHFLOW NOTICES
LONDON, UK – DECEMEMBER 21, 2020 – Accelex, a data acquisition, analytics and reporting solution for private markets investors and asset servicers, is pleased to announce they have reached an agreement with a leading life sciences investor. Accelex will help this major European client automate the data extraction from hundreds of investment documents, including fund performance reports, capital account statements, capital call and distribution notices.
“With the growth of our private investments business, bringing automation to inefficient manual processes is paramount”, remarked the company’s director of portfolio valuations and performance. “We are excited by the data management opportunities Accelex brings to our firm. The solution enables us to deliver better performance reporting and analytics along with improved workflows for our cashflow events”.
“Our latest client is an internationally recognized investor in the field of life sciences. We are excited to deliver our solution as an integral part of their digital transformation” said Michael Aldridge, President at Accelex. “With the firm joining our growing community of major private markets investors, we are thrilled to partner with this outstanding organization in the provision of our market leading technology”.
Accelex provides a data acquisition, analytics and reporting solution for investors and asset servicers enabling firms to fully leverage their investment data. Powered by proprietary data science techniques, Accelex automates processes for extraction, analysis and sharing of critical investment performance and transaction data. The solution has been developed to simplify the demanding workflow requirements of investors. Headquartered in London, Accelex has offices in Paris, New York and Toronto.